Resveratrol- from the bottle to the bedside?

Leukemia and Lymphoma

Volumn 40, Issue 5-6, 2001, Pages 491-498

  Pervaiz, S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Caspases; CD95 system; Mitochondria; Resveratrol; Tumor cells

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; ESTROGEN; FAS ANTIGEN; FAS LIGAND; GROWTH INHIBITOR; GROWTH PROMOTOR; NATURAL PRODUCT; POLYPHENOL DERIVATIVE; PROTEINASE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROGENESIS; BLOOD CELL; BREAST CARCINOMA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; CELL SURFACE; CELL TRANSFORMATION; CELL TYPE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MITOCHONDRION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKIN PAPILLOMA;

EID: 0035052942     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097648     Document Type: Review

References (58)

1. The stilbenoids
2. Resveratrol: A molecule whose time has come? And gone?
3. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon. (Polygonum cuspidatum SIEB et ZUCC)
4. A new class of phytoalexins
5. Identification of pterostilbene as a phytoalexin from Vitis ninifera leaves
6. The relationship of resveratrol production to infection of grapevine leaves by Botrytis cinera
7. Concentration of the phytoalexin resveratrol in wine
8. Alcohol, ischemic heart disease, and the French paradox
9. Myocardial protection with red wine extract
10. Antiplatelet activity of synthetic and natural resveratrol in red wine
11. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells
12. Biological effects of resveratrol
13. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
14. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
15. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein
16. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages
17. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol
18. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
19. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
20. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
21. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials
22. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
23. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
24. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
25. Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids
26. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model
27. Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases
28. Human ICE/CED-3 protease nomenclature
29. Activation of programmed cell death by anticancer agents: Cisplatin as a model system
30. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
31. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
32. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
33. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
34. Programmed cell death in the immune system
35. Autocrine T-cell suicide mediated by APO-1(Fas/CD95)
36. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
37. Lethal effect of the anti-Fas antibody in mice
38. Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin
39. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors
40. Cytotoxic drugs and the CD95 pathway
41. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis
42. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
43. Two CD95 (APO-1/Fas) signaling pathways
44. Purified photoproducts of merocyanine 540 trigger cytochrome C release and caspase 8-dependent apoptosis in human leukemia and melanoma cells
45. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation
46. An APAF-1. Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
47. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis
48. Mitochondrial permeability transition is a central coordinating event of apoptosis
49. The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins
50. The central role of the mitochondrial megachannel in apoptosis: Evidence obtained with intact cells, isolated mitochondria, and purified protein complexes
51. Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition
52. Mitochondria as regulators of apoptosis: Doubt no more
53. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c
54. Superoxide anion inhibits drug-induced tumor cell death
55. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: An hypothesis
56. Antioxidant enzyme levels as a function of growth state in cell culture
57. Antioxidant enzyme levels in cancer
58. Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells